HSP90/mTOR-IN-1 is used for the study of bladder cancer; it exhibits potent anti-tumor activity in xenograft mouse models by selectively inhibiting Hsp90 and mTOR, thereby inducing apoptosis and autophagy, and suppressing SW780 cell proliferation through hyperactivation of the PI3K/AKT/mTOR pathway.